Promoter methylation analysis of WNT/β-catenin pathway regulators and its association with expression of DNMT1 enzyme in colorectal cancer

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Samaei, Nader Mansour ^a   Yazdani, Yaghoub ^a   Alizadeh Navaei, Reza ^b   Azadeh, Hossein ^c   Farazmandfar, Touraj ^a,b,c  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; DNMT1; Promoter methylation; WNT catenin signaling

Indexed keywords

BETA CATENIN; DNA METHYLTRANSFERASE 1; MESSENGER RNA; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 4; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX7; WNT PROTEIN; WNT5A PROTEIN; DNA; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; TUMOR PROTEIN;

ADULT; AGE; ARTICLE; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENDER; HUMAN; HUMAN TISSUE; MALE; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; WNT SIGNALING PATHWAY; AGED; CLINICAL TRIAL; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; BETA CATENIN; COLORECTAL NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; SEX FACTORS; WNT SIGNALING PATHWAY;

EID: 84907061280     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/s12929-014-0073-3     Document Type: Article

References (26)

1. Cancer statistics, 2008. A Jemal, R Siegel, E Ward, Y Hao, J Xu, T Murray, MJ Thun, CA Cancer J Clin 2008 58 71 96 10.3322/CA.2007.0010 18287387
2. CpG island methylator phenotype in cancer. J-P Issa, Nat Rev Cancer 2004 4 988 993 10.1038/nrc1507 15573120
3. Epigenetic changes in colorectal cancer. Y Kondo, J-PJ Issa, Cancer Metastasis Rev 2004 23 29 39 10.1023/A:1025806911782 15000147
4. Molecular origins of cancer: molecular basis of colorectal cancer. SD Markowitz, MM Bertagnolli, N Engl J Med 2009 361 2449 2460 10.1056/NEJMra0804588 20018966
5. Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation. AH Ting, K Jair, KE Schuebel, SB Baylin, Cancer Res 2006 66 729 735 10.1158/0008-5472.CAN-05-1537 16424002
6. De novo CpG island methylation in human cancer cells. K-W Jair, KE Bachman, H Suzuki, AH Ting, I Rhee, R-WC Yen, SB Baylin, KE Schuebel, Cancer Res 2006 66 682 692 10.1158/0008-5472.CAN-05-1980 16423997
7. Regulation of metastasis in colorectal adenocarcinoma: a collision between development and tumor biology. JJ Smith, NG Deane, P Dhawan, RD Beauchamp, Surgery 2008 144 353 366 10.1016/j.surg.2008.05.007 18707034
8. Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3. J Veeck, E Dahl, Biochim Biophys Acta 1825 2012 18 28
9. Linking colorectal cancer to Wnt signaling. M Bienz, H Clevers, Cell 2000 103 311 320 10.1016/S0092-8674(00)00122-7 11057903
10. APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q. CN Arnold, A Goel, D Niedzwiecki, JM Dowell, L Wasserman, C Compton, RJ Mayer, MM Bertagnolli, CR Boland, Cancer Biol Ther 2004 3 960 964 10.4161/cbt.3.10.1113 15326380
11. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. K Koinuma, Y Yamashita, W Liu, H Hatanaka, K Kurashina, T Wada, S Takada, R Kaneda, YL Choi, S-I Fujiwara, Y Miyakura, H Nagai, H Mano, Oncogene 2006 25 139 146 16247484
12. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. J Yu, Q Tao, YY Cheng, KY Lee, SSM Ng, KF Cheung, L Tian, SY Rha, U Neumann, C Röcken, MPA Ebert, FKL Chan, JJY Sung, Cancer 2009 115 49 60 10.1002/cncr.23989 19051296
13. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. J Qi, Y-Q Zhu, J Luo, W-H Tao, World J Gastroenterol 2006 12 7113 7117 17131472
14. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. LH Sobin, ID Fleming, Cancer 1997 80 1803 1804 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9 9351551
15. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix. WF Van der Meide, S Snellenberg, CJLM Meijer, A Baalbergen, TJM Helmerhorst, WB van der Sluis, PJF Snijders, RDM Steenbergen, Gynecol Oncol 2011 123 116 122 10.1016/j.ygyno.2011.06.015 21726894
16. Analyzing real-time PCR data by the comparative C(T) method. TD Schmittgen, KJ Livak, Nat Protoc 2008 3 1101 1108 10.1038/nprot.2008.73 18546601
17. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers. Y Ying, Q Tao, Epigenetics 2009 4 307 312 10.4161/epi.4.5.9371 19633433
18. Epigenetic diagnostics of cancer-the application of DNA methylation markers. J Paluszczak, W Baer-Dubowska, J Appl Genet 2006 47 365 375 10.1007/BF03194647 17132902
19. DNA methylation and cancer. M Kulis, M Esteller, Adv Genet 2010 70 27 56 10.1016/B978-0-12-380866-0.60002-2 20920744
20. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis. J Chen, C Röcken, C Lofton-Day, H-U Schulz, O Müller, N Kutzner, P Malfertheiner, MPA Ebert, Carcinogenesis 2005 26 37 43 10.1093/carcin/bgh280 15375009
21. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. M Esteller, A Sparks, M Toyota, M Sanchez-Cespedes, G Capella, MA Peinado, S Gonzalez, G Tarafa, D Sidransky, SJ Meltzer, SB Baylin, JG Herman, Cancer Res 2000 60 4366 4371 10969779
22. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer. B Iacopetta, F Grieu, W Li, A Ruszkiewicz, M Caruso, J Moore, G Watanabe, K Kawakami, Int J Cancer 2006 119 2272 2278 10.1002/ijc.22237 16981189
23. Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas. X Fu, J Li, K Li, X Tian, Y Zhang, Histopathology 2009 55 554 563 10.1111/j.1365-2559.2009.03411.x 19912361
24. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. BB Lee, EJ Lee, EH Jung, H-K Chun, DK Chang, SY Song, J Park, D-H Kim, Clin Cancer Res 2009 15 6185 6191 10.1158/1078-0432.CCR-09-0111 19773381
25. Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients. JB Rawson, M Mrkonjic, D Daftary, E Dicks, DD Buchanan, HB Younghusband, PS Parfrey, JP Young, A Pollett, RC Green, S Gallinger, JR McLaughlin, JA Knight, B Bapat, Br J Cancer 2011 104 1906 1912 10.1038/bjc.2011.165 21587258
26. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. AH Ting, K Jair, H Suzuki, R-WC Yen, SB Baylin, KE Schuebel, Nat Genet 2004 36 582 584 10.1038/ng1365 15156141